{"id":5315,"date":"2021-02-25T10:17:00","date_gmt":"2021-02-25T10:17:00","guid":{"rendered":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/"},"modified":"2024-09-23T11:22:29","modified_gmt":"2024-09-23T11:22:29","slug":"onderzoeksupdate-disease-modifying-therapies","status":"publish","type":"post","link":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/","title":{"rendered":"Onderzoeksupdate: Disease Modifying Therapies"},"content":{"rendered":"

Elke maand krijgen we vanuit Breakthrough T1D International de laatste updates op het gebied van onderzoek naar type 1 diabetes (T1D). In de maand januari ging deze update over therapie\u00ebn die het verloop van T1D kunnen be\u00efnvloeden. De therapie\u00ebn dragen bij aan het voorkomen, uitstellen of genezen van type 1. <\/strong><\/p>\n

Dit kan worden gedaan via het remmen van de auto-immuunaanval op insulineproducerende b\u00e8tacellen. Ook richten sommige therapie\u00ebn zich op het versterken of opnieuw aanmaken van b\u00e8tacellen. Wanneer het gaat over al deze soorten therapie\u00ebn dan spreekt men van \u201cdisease modyfying therapies (DMT\u2019s).<\/p>\n

Projecten<\/strong><\/h3>\n

Op dit moment zijn er een aantal veelbelovende DMT\u2019s die aangetoond hebben de ontwikkeling van type 1 diabetes te vertragen of te stoppen. Deze therapie\u00ebn be\u00efnvloeden op verschillende manieren het verloop van de ziekte. <\/em>Vaak is sprake van gebruik van geneesmiddelen die al eerder zijn toegelaten voor andere ziekten. Dit is een groot voordeel omdat veiligheid dan al (gedeeltelijk) is aangetoond en daarmee een deel van de kosten van de ontwikkeling van de therapie bespaard kunnen worden. <\/p>\n

Breakthrough T1D steunt onderzoek naar DMT\u2019s. Het doel is om de therapie\u00ebn zo snel mogelijk in handen van mensen met type 1 te krijgen, maar voordat dit kan is er nog veel onderzoek nodig. Om dit onderzoek te doen is er geld nodig. Doneer<\/a> daarom aan Breakthrough T1D, zodat wetenschappers deze therapie\u00ebn verder kunnen ontwikkelen. Zo krijgen we type 1 diabetes de wereld uit.<\/p>\n

Voor meer informatie over DMT\u2019s en de projecten klik hier.<\/a> <\/em><\/p>\n

\n

Type 1 diabetes (T1D) de wereld uit helpen: dat is de missie van Breakthrough T1D. Om dit te bereiken werken wij wereldwijd samen voor het beste wetenschappelijk onderzoek. Jouw steun maakt dat een oplossing voor T1D dichterbij komt. Samen maken we van type \u00e9\u00e9n, type g\u00e9\u00e9n!<\/p>\n \n

\n
Help ons<\/a><\/div>\n <\/div>\n <\/div>","protected":false,"raw":""},"excerpt":{"rendered":"

Elke maand krijgen we vanuit Breakthrough T1D International de laatste updates op het gebied van onderzoek naar type 1 diabetes (T1D). In de maand januari ging deze update over therapie\u00ebn die het verloop van T1D kunnen be\u00efnvloeden. De therapie\u00ebn dragen bij aan het voorkomen, uitstellen of genezen van type 1. Dit kan worden gedaan via […]<\/p>\n","protected":false},"author":1,"featured_media":5316,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[184,188,195],"tags":[],"class_list":["post-5315","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-archief","category-genezen","category-voorkomen"],"yoast_head":"\nOnderzoeksupdate: Disease Modifying Therapies - Breakthrough T1D<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Onderzoeksupdate: Disease Modifying Therapies - Breakthrough T1D\" \/>\n<meta property=\"og:description\" content=\"Elke maand krijgen we vanuit Breakthrough T1D International de laatste updates op het gebied van onderzoek naar type 1 diabetes (T1D). In de maand januari ging deze update over therapie\u00ebn die het verloop van T1D kunnen be\u00efnvloeden. De therapie\u00ebn dragen bij aan het voorkomen, uitstellen of genezen van type 1. Dit kan worden gedaan via […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/\" \/>\n<meta property=\"og:site_name\" content=\"Breakthrough T1D\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-25T10:17:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-23T11:22:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2021\/02\/onderzoek_wetenschap_microscoop_stockbeeld_Breakthrough%20T1DI-3-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ylt-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"ylt-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/\"},\"author\":{\"name\":\"ylt-admin\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\"},\"headline\":\"Onderzoeksupdate: Disease Modifying Therapies\",\"datePublished\":\"2021-02-25T10:17:00+00:00\",\"dateModified\":\"2024-09-23T11:22:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/\"},\"wordCount\":314,\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2021\/02\/onderzoek_wetenschap_microscoop_stockbeeld_Breakthrough T1DI-3-scaled.jpg\",\"articleSection\":[\"Archief\",\"Genezen\",\"Voorkomen\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/\",\"name\":\"Onderzoeksupdate: Disease Modifying Therapies - Breakthrough T1D\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2021\/02\/onderzoek_wetenschap_microscoop_stockbeeld_Breakthrough T1DI-3-scaled.jpg\",\"datePublished\":\"2021-02-25T10:17:00+00:00\",\"dateModified\":\"2024-09-23T11:22:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/#primaryimage\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2021\/02\/onderzoek_wetenschap_microscoop_stockbeeld_Breakthrough T1DI-3-scaled.jpg\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2021\/02\/onderzoek_wetenschap_microscoop_stockbeeld_Breakthrough T1DI-3-scaled.jpg\",\"width\":2560,\"height\":1707},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/breakthrought1d.eu\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Onderzoeksupdate: Disease Modifying Therapies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"name\":\"Breakthrough T1D\",\"description\":\"Wij zetten ons in voor een toekomst zonder T1D\",\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\",\"name\":\"Breakthrough T1D\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"width\":330,\"height\":141,\"caption\":\"Breakthrough T1D\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\",\"name\":\"ylt-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"caption\":\"ylt-admin\"},\"sameAs\":[\"https:\/\/87.250.144.92\"],\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Onderzoeksupdate: Disease Modifying Therapies - Breakthrough T1D","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/","og_locale":"nl_NL","og_type":"article","og_title":"Onderzoeksupdate: Disease Modifying Therapies - Breakthrough T1D","og_description":"Elke maand krijgen we vanuit Breakthrough T1D International de laatste updates op het gebied van onderzoek naar type 1 diabetes (T1D). In de maand januari ging deze update over therapie\u00ebn die het verloop van T1D kunnen be\u00efnvloeden. De therapie\u00ebn dragen bij aan het voorkomen, uitstellen of genezen van type 1. Dit kan worden gedaan via […]","og_url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/","og_site_name":"Breakthrough T1D","article_published_time":"2021-02-25T10:17:00+00:00","article_modified_time":"2024-09-23T11:22:29+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2021\/02\/onderzoek_wetenschap_microscoop_stockbeeld_Breakthrough T1DI-3-scaled.jpg","type":"image\/jpeg"}],"author":"ylt-admin","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"ylt-admin","Geschatte leestijd":"2 minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/#article","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/"},"author":{"name":"ylt-admin","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6"},"headline":"Onderzoeksupdate: Disease Modifying Therapies","datePublished":"2021-02-25T10:17:00+00:00","dateModified":"2024-09-23T11:22:29+00:00","mainEntityOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/"},"wordCount":314,"publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2021\/02\/onderzoek_wetenschap_microscoop_stockbeeld_Breakthrough T1DI-3-scaled.jpg","articleSection":["Archief","Genezen","Voorkomen"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/","url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/","name":"Onderzoeksupdate: Disease Modifying Therapies - Breakthrough T1D","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/#primaryimage"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2021\/02\/onderzoek_wetenschap_microscoop_stockbeeld_Breakthrough T1DI-3-scaled.jpg","datePublished":"2021-02-25T10:17:00+00:00","dateModified":"2024-09-23T11:22:29+00:00","breadcrumb":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/#primaryimage","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2021\/02\/onderzoek_wetenschap_microscoop_stockbeeld_Breakthrough T1DI-3-scaled.jpg","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2021\/02\/onderzoek_wetenschap_microscoop_stockbeeld_Breakthrough T1DI-3-scaled.jpg","width":2560,"height":1707},{"@type":"BreadcrumbList","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-disease-modifying-therapies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/breakthrought1d.eu\/nl\/"},{"@type":"ListItem","position":2,"name":"Onderzoeksupdate: Disease Modifying Therapies"}]},{"@type":"WebSite","@id":"https:\/\/breakthrought1d.eu\/nl\/#website","url":"https:\/\/breakthrought1d.eu\/nl\/","name":"Breakthrough T1D","description":"Wij zetten ons in voor een toekomst zonder T1D","publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/breakthrought1d.eu\/nl\/#organization","name":"Breakthrough T1D","url":"https:\/\/breakthrought1d.eu\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","width":330,"height":141,"caption":"Breakthrough T1D"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6","name":"ylt-admin","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","caption":"ylt-admin"},"sameAs":["https:\/\/87.250.144.92"],"url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5315","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/comments?post=5315"}],"version-history":[{"count":2,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5315\/revisions"}],"predecessor-version":[{"id":8858,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5315\/revisions\/8858"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media\/5316"}],"wp:attachment":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media?parent=5315"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/categories?post=5315"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/tags?post=5315"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}